MP
MD icon

Mangrove Partners’s Pediatrix Medical MD Stock Holding History

Mangrove Partners’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,977
Closed -$385K – 525
2026
Q1 		$385K Sell
17,977
-4,407
-20% -$91.7K 0.03% 231
2025
Q4 		$479K Buy
+22,384
New +$459K 0.04% 164

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Mangrove Partners's MD Position: Q2 2026 in Review

Mangrove Partners sold out of Pediatrix Medical (MD) in Q2 2026, closing a stake of 17,977 shares — an estimated $385K sold.

Mangrove Partners first reported a position in MD in Q4 2025 and held it in 2 quarters. The position peaked at $479K in Q4 2025. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Mangrove Partners reported no remaining Pediatrix Medical position as of Q2 2026 after selling out during the quarter.
  • Mangrove Partners sold 17,977 Pediatrix Medical shares in Q2 2026, an estimated $385K.
  • Mangrove Partners first reported a position in Pediatrix Medical in Q4 2025 and held it in 2 quarters.
  • Mangrove Partners's Pediatrix Medical position peaked at $479K in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Mangrove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.